SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021092
Filing Date
2021-11-02
Accepted
2021-11-02 09:03:58
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20210930.htm   iXBRL 10-Q 1298042
2 EX-31.1 espr-ex311x09302021.htm EX-31.1 11065
3 EX-31.2 espr-ex312x09302021.htm EX-31.2 11137
4 EX-32.1 espr-ex321x09302021.htm EX-32.1 7619
  Complete submission text file 0001628280-21-021092.txt   6503167

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20210930.xsd EX-101.SCH 55322
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20210930_cal.xml EX-101.CAL 51015
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20210930_def.xml EX-101.DEF 275201
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20210930_lab.xml EX-101.LAB 636600
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20210930_pre.xml EX-101.PRE 423899
10 EXTRACTED XBRL INSTANCE DOCUMENT espr-20210930_htm.xml XML 954263
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 211369473
SIC: 2834 Pharmaceutical Preparations